Natco Pharma Limited has informed the Exchange about Copy of Newspaper Publication
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma has filed copies of newspaper publications related to its Postal Ballot Notice, as required under SEBI Listing Regulations. The Postal Ballot seeks shareholder approval for 4 special resolutions to reappoint key directors: V.C. Nannapaneni as Chairman & Managing Director, Rajeev Nannapaneni as Vice Chairman & CEO, P.S.R.K Prasad as Director & Executive Vice President (Corporate Engineering Services), and Dr. D. Linga Rao as Director & President (Technical Affairs). The remote e-voting window runs from February 23, 2026 (9:00 AM IST) to March 24, 2026 (5:00 PM IST), with the cut-off date set at February 13, 2026. The scrutinizer is M/s. BK & Associates, and voting results will be announced on or before March 26, 2026. Members can vote only through remote e-voting, as physical postal ballot forms have been dispensed with per MCA circulars.
This is a routine procedural filing for director reappointments and is unlikely to have a material impact on the stock price. Shareholders holding shares as of the cut-off date (Feb 13, 2026) should review the resolutions and exercise their e-voting rights before March 24, 2026.